Policy analysis of access to and reimbursement for nonpharmacologic therapies for cancer-related fatigue

Dilorom Djalilova, Natalie Mandolfo, Ann M. Berger, Mary E. Cramer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cancer-related fatigue (CRF) is an important public health issue that involves millions of community-dwelling cancer survivors. CRF is the most debilitating patient reported symptom related to cancer therapies and exacts a significant economic and social toll. It adversely impacts patients' work, social relationships, and overall quality of life. CRF prevalence ranges from 30% to 90% during therapy and often persists months and years afterwards. This policy analysis examines the problem of lack of patient access to evidence-based nonpharmacologic CRF therapies. The authors use a five-step process described by Teitelbaum & Wilenski (2017) to address the problem statement, identify key stakeholders, explore problem landscape, describe two viable policy options, and make a recommendation. The two policy options considered were: (a) insurer reimbursements modeled after existing cardiac rehabilitation programs and (b) health care provider incentives that incorporate the oncology care model (OCM) quality measure. Advantages and disadvantages of both options are presented. Public health nurses are uniquely positioned in their communities to advocate for these changes to improve population health.

Original languageEnglish (US)
Pages (from-to)545-550
Number of pages6
JournalPublic Health Nursing
Volume36
Issue number4
DOIs
StatePublished - Jul 1 2019

Fingerprint

Second Primary Neoplasms
Policy Making
Fatigue
Neoplasms
Independent Living
Public Health Nurses
Insurance Carriers
Quality of Health Care
Health Personnel
Survivors
Motivation
Public Health
Economics
Quality of Life
Health
Population
Therapeutics

Keywords

  • access
  • cancer-related fatigue
  • insurance
  • policy analysis
  • reimbursement

ASJC Scopus subject areas

  • Nursing(all)
  • Public Health, Environmental and Occupational Health

Cite this

Policy analysis of access to and reimbursement for nonpharmacologic therapies for cancer-related fatigue. / Djalilova, Dilorom; Mandolfo, Natalie; Berger, Ann M.; Cramer, Mary E.

In: Public Health Nursing, Vol. 36, No. 4, 01.07.2019, p. 545-550.

Research output: Contribution to journalArticle

@article{258d847f43954678841622412baa4899,
title = "Policy analysis of access to and reimbursement for nonpharmacologic therapies for cancer-related fatigue",
abstract = "Cancer-related fatigue (CRF) is an important public health issue that involves millions of community-dwelling cancer survivors. CRF is the most debilitating patient reported symptom related to cancer therapies and exacts a significant economic and social toll. It adversely impacts patients' work, social relationships, and overall quality of life. CRF prevalence ranges from 30{\%} to 90{\%} during therapy and often persists months and years afterwards. This policy analysis examines the problem of lack of patient access to evidence-based nonpharmacologic CRF therapies. The authors use a five-step process described by Teitelbaum & Wilenski (2017) to address the problem statement, identify key stakeholders, explore problem landscape, describe two viable policy options, and make a recommendation. The two policy options considered were: (a) insurer reimbursements modeled after existing cardiac rehabilitation programs and (b) health care provider incentives that incorporate the oncology care model (OCM) quality measure. Advantages and disadvantages of both options are presented. Public health nurses are uniquely positioned in their communities to advocate for these changes to improve population health.",
keywords = "access, cancer-related fatigue, insurance, policy analysis, reimbursement",
author = "Dilorom Djalilova and Natalie Mandolfo and Berger, {Ann M.} and Cramer, {Mary E.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1111/phn.12615",
language = "English (US)",
volume = "36",
pages = "545--550",
journal = "Public Health Nursing",
issn = "0737-1209",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Policy analysis of access to and reimbursement for nonpharmacologic therapies for cancer-related fatigue

AU - Djalilova, Dilorom

AU - Mandolfo, Natalie

AU - Berger, Ann M.

AU - Cramer, Mary E.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Cancer-related fatigue (CRF) is an important public health issue that involves millions of community-dwelling cancer survivors. CRF is the most debilitating patient reported symptom related to cancer therapies and exacts a significant economic and social toll. It adversely impacts patients' work, social relationships, and overall quality of life. CRF prevalence ranges from 30% to 90% during therapy and often persists months and years afterwards. This policy analysis examines the problem of lack of patient access to evidence-based nonpharmacologic CRF therapies. The authors use a five-step process described by Teitelbaum & Wilenski (2017) to address the problem statement, identify key stakeholders, explore problem landscape, describe two viable policy options, and make a recommendation. The two policy options considered were: (a) insurer reimbursements modeled after existing cardiac rehabilitation programs and (b) health care provider incentives that incorporate the oncology care model (OCM) quality measure. Advantages and disadvantages of both options are presented. Public health nurses are uniquely positioned in their communities to advocate for these changes to improve population health.

AB - Cancer-related fatigue (CRF) is an important public health issue that involves millions of community-dwelling cancer survivors. CRF is the most debilitating patient reported symptom related to cancer therapies and exacts a significant economic and social toll. It adversely impacts patients' work, social relationships, and overall quality of life. CRF prevalence ranges from 30% to 90% during therapy and often persists months and years afterwards. This policy analysis examines the problem of lack of patient access to evidence-based nonpharmacologic CRF therapies. The authors use a five-step process described by Teitelbaum & Wilenski (2017) to address the problem statement, identify key stakeholders, explore problem landscape, describe two viable policy options, and make a recommendation. The two policy options considered were: (a) insurer reimbursements modeled after existing cardiac rehabilitation programs and (b) health care provider incentives that incorporate the oncology care model (OCM) quality measure. Advantages and disadvantages of both options are presented. Public health nurses are uniquely positioned in their communities to advocate for these changes to improve population health.

KW - access

KW - cancer-related fatigue

KW - insurance

KW - policy analysis

KW - reimbursement

UR - http://www.scopus.com/inward/record.url?scp=85064075830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064075830&partnerID=8YFLogxK

U2 - 10.1111/phn.12615

DO - 10.1111/phn.12615

M3 - Article

C2 - 30968452

AN - SCOPUS:85064075830

VL - 36

SP - 545

EP - 550

JO - Public Health Nursing

JF - Public Health Nursing

SN - 0737-1209

IS - 4

ER -